| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Reticulocytes | 8 | 2003 | 23 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 10 | 2001 | 23 |
Why?
|
Lung Neoplasms | 11 | 2001 | 159 |
Why?
|
Micronuclei, Chromosome-Defective | 4 | 2007 | 9 |
Why?
|
Radiation-Sensitizing Agents | 5 | 2001 | 29 |
Why?
|
Paclitaxel | 5 | 2001 | 37 |
Why?
|
Radiation Pneumonitis | 6 | 2001 | 12 |
Why?
|
Gamma Rays | 3 | 2009 | 38 |
Why?
|
Neoplasms | 8 | 2003 | 239 |
Why?
|
Thoracic Neoplasms | 4 | 2001 | 16 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 2003 | 23 |
Why?
|
Bone Marrow Cells | 2 | 2009 | 92 |
Why?
|
Micronucleus Tests | 6 | 2003 | 9 |
Why?
|
Flow Cytometry | 12 | 1988 | 216 |
Why?
|
Dose-Response Relationship, Radiation | 9 | 2003 | 85 |
Why?
|
Radiation Injuries, Experimental | 3 | 2005 | 37 |
Why?
|
Whole-Body Irradiation | 4 | 1999 | 43 |
Why?
|
Interleukin-6 | 4 | 2001 | 145 |
Why?
|
Radiation Oncology | 2 | 2006 | 11 |
Why?
|
Chromosome Aberrations | 3 | 2003 | 45 |
Why?
|
Taxoids | 1 | 2010 | 12 |
Why?
|
Combined Modality Therapy | 5 | 2003 | 219 |
Why?
|
Cell Cycle | 9 | 1988 | 121 |
Why?
|
Radiometry | 1 | 2010 | 31 |
Why?
|
Radiotherapy Dosage | 9 | 2001 | 55 |
Why?
|
Biological Assay | 1 | 2010 | 58 |
Why?
|
Pneumonectomy | 2 | 2008 | 15 |
Why?
|
Radiation Injuries | 3 | 2006 | 63 |
Why?
|
Neoplastic Stem Cells | 1 | 2009 | 21 |
Why?
|
Palliative Care | 1 | 2010 | 65 |
Why?
|
Biological Markers | 6 | 2001 | 262 |
Why?
|
Biomedical Research | 1 | 2009 | 87 |
Why?
|
Cesium Radioisotopes | 1 | 2007 | 18 |
Why?
|
Middle Aged | 18 | 2001 | 1161 |
Why?
|
Clinical Trials as Topic | 2 | 2004 | 251 |
Why?
|
Aged, 80 and over | 10 | 2001 | 599 |
Why?
|
Automation | 1 | 2006 | 27 |
Why?
|
Adult | 19 | 1988 | 1317 |
Why?
|
Aged | 14 | 2001 | 988 |
Why?
|
Interleukin-1 | 2 | 2002 | 109 |
Why?
|
Nuclear Energy | 1 | 2006 | 2 |
Why?
|
Humans | 37 | 1988 | 1856 |
Why?
|
Radiobiology | 1 | 2006 | 9 |
Why?
|
Female | 23 | 1988 | 1643 |
Why?
|
International Agencies | 1 | 2006 | 6 |
Why?
|
Male | 21 | 1988 | 1553 |
Why?
|
Cytokines | 3 | 2002 | 207 |
Why?
|
Dose Fractionation | 4 | 2009 | 25 |
Why?
|
Mice | 11 | 1990 | 623 |
Why?
|
Genetic Testing | 1 | 2003 | 49 |
Why?
|
Drug Administration Schedule | 3 | 2001 | 191 |
Why?
|
Radiotherapy | 3 | 2003 | 73 |
Why?
|
Oxygen | 1 | 2005 | 179 |
Why?
|
Platelet-Derived Growth Factor | 3 | 1989 | 37 |
Why?
|
Epidermal Growth Factor | 3 | 1989 | 51 |
Why?
|
Neoplasms, Experimental | 1 | 2001 | 72 |
Why?
|
Bioreactors | 2 | 2009 | 8 |
Why?
|
Genetic Predisposition to Disease | 1 | 2003 | 131 |
Why?
|
Somatomedins | 2 | 1989 | 9 |
Why?
|
Animals | 15 | 1990 | 1031 |
Why?
|
Neoplasm Staging | 3 | 2008 | 125 |
Why?
|
Insulin-Like Growth Factor I | 2 | 1989 | 64 |
Why?
|
Follow-Up Studies | 4 | 2001 | 553 |
Why?
|
Head and Neck Neoplasms | 2 | 2007 | 47 |
Why?
|
Radiosurgery | 2 | 2009 | 24 |
Why?
|
Cell Survival | 2 | 1990 | 229 |
Why?
|
Antineoplastic Agents | 5 | 2003 | 190 |
Why?
|
Cells, Cultured | 7 | 1988 | 447 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2001 | 210 |
Why?
|
DNA Damage | 4 | 2003 | 66 |
Why?
|
Retrospective Studies | 5 | 2008 | 653 |
Why?
|
Mitosis | 2 | 1990 | 68 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2001 | 224 |
Why?
|
Treatment Outcome | 6 | 2008 | 661 |
Why?
|
Fibroblasts | 3 | 1988 | 179 |
Why?
|
Cisplatin | 3 | 2009 | 43 |
Why?
|
Mice, Inbred C57BL | 3 | 2009 | 318 |
Why?
|
Survival Rate | 4 | 2009 | 250 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 121 |
Why?
|
Tumor Cells, Cultured | 3 | 2001 | 233 |
Why?
|
Sensitivity and Specificity | 2 | 2005 | 427 |
Why?
|
Proportional Hazards Models | 3 | 2008 | 123 |
Why?
|
Time Factors | 5 | 1989 | 896 |
Why?
|
Tumor Markers, Biological | 2 | 2003 | 112 |
Why?
|
Severity of Illness Index | 2 | 2006 | 358 |
Why?
|
Tomography, X-Ray Computed | 3 | 2003 | 321 |
Why?
|
Skin | 2 | 1989 | 177 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 2011 | 6 |
Why?
|
Stomatitis | 1 | 2011 | 10 |
Why?
|
Culture Media | 2 | 1988 | 116 |
Why?
|
Erythroid Cells | 1 | 2011 | 8 |
Why?
|
Tumor Stem Cell Assay | 1 | 2010 | 21 |
Why?
|
Recombinant Proteins | 2 | 2010 | 290 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1992 | 74 |
Why?
|
Nausea | 2 | 2007 | 34 |
Why?
|
Bromodeoxyuridine | 4 | 1988 | 47 |
Why?
|
Translational Medical Research | 1 | 2010 | 20 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2010 | 34 |
Why?
|
Erythropoiesis | 1 | 2010 | 25 |
Why?
|
Remission Induction | 1 | 2010 | 64 |
Why?
|
Cell Line, Tumor | 2 | 2003 | 208 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2009 | 118 |
Why?
|
Radiation Dosage | 1 | 2010 | 65 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2009 | 11 |
Why?
|
Information Dissemination | 1 | 2009 | 19 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 32 |
Why?
|
Acupressure | 1 | 2009 | 8 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2009 | 25 |
Why?
|
Cell Hypoxia | 1 | 2009 | 31 |
Why?
|
Pilot Projects | 1 | 2010 | 264 |
Why?
|
Prospective Studies | 2 | 2001 | 545 |
Why?
|
Infusions, Intravenous | 1 | 2008 | 87 |
Why?
|
Quinuclidines | 1 | 2007 | 2 |
Why?
|
Muscarinic Agonists | 1 | 2007 | 15 |
Why?
|
Kinetics | 2 | 1988 | 349 |
Why?
|
Thiophenes | 1 | 2007 | 15 |
Why?
|
Xerostomia | 1 | 2007 | 19 |
Why?
|
Bisbenzimidazole | 3 | 1988 | 6 |
Why?
|
Hematopoietic Stem Cells | 1 | 2009 | 69 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 2 | 2003 | 11 |
Why?
|
Reproducibility of Results | 1 | 2010 | 391 |
Why?
|
Dictionaries as Topic | 1 | 2006 | 1 |
Why?
|
Radiation-Protective Agents | 1 | 2006 | 28 |
Why?
|
New York | 1 | 2010 | 422 |
Why?
|
Age Factors | 1 | 2009 | 480 |
Why?
|
Lung | 2 | 1988 | 232 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2005 | 7 |
Why?
|
Terminology as Topic | 1 | 2006 | 81 |
Why?
|
Antigens, CD | 2 | 2003 | 128 |
Why?
|
ROC Curve | 1 | 2005 | 80 |
Why?
|
History, 21st Century | 1 | 2005 | 36 |
Why?
|
Cell Differentiation | 1 | 2011 | 262 |
Why?
|
Smoking | 1 | 2008 | 153 |
Why?
|
Intestines | 1 | 2005 | 83 |
Why?
|
Apoptosis | 3 | 2003 | 265 |
Why?
|
Anoxia | 1 | 2005 | 85 |
Why?
|
History, 20th Century | 1 | 2005 | 111 |
Why?
|
Information Services | 1 | 2003 | 21 |
Why?
|
Research | 1 | 2005 | 124 |
Why?
|
Maximum Tolerated Dose | 1 | 2003 | 18 |
Why?
|
G2 Phase | 1 | 2003 | 20 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2003 | 47 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 321 |
Why?
|
Sulfonamides | 1 | 2003 | 74 |
Why?
|
Surgical Procedures, Operative | 1 | 2003 | 77 |
Why?
|
Transplantation, Heterologous | 1 | 2001 | 57 |
Why?
|
Necrosis | 1 | 2001 | 82 |
Why?
|
Models, Biological | 1 | 2007 | 410 |
Why?
|
Neoplasm Transplantation | 1 | 2001 | 67 |
Why?
|
Mesothelioma | 1 | 2001 | 22 |
Why?
|
Postoperative Complications | 1 | 2006 | 305 |
Why?
|
Isoenzymes | 1 | 2003 | 144 |
Why?
|
Risk Factors | 2 | 2002 | 555 |
Why?
|
Transplantation Conditioning | 1 | 1999 | 23 |
Why?
|
Prognosis | 1 | 2003 | 388 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1999 | 49 |
Why?
|
Cyclophosphamide | 1 | 1999 | 82 |
Why?
|
Comorbidity | 2 | 2008 | 190 |
Why?
|
Bone Marrow Transplantation | 1 | 1999 | 90 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1990 | 431 |
Why?
|
Breast Neoplasms | 1 | 2003 | 185 |
Why?
|
Ethidium | 1 | 1994 | 14 |
Why?
|
Receptors, Transferrin | 2 | 2003 | 14 |
Why?
|
Staining and Labeling | 2 | 1990 | 101 |
Why?
|
Tissue Survival | 1 | 1992 | 5 |
Why?
|
Phosphocreatine | 1 | 1992 | 11 |
Why?
|
Organophosphorus Compounds | 1 | 1992 | 14 |
Why?
|
Hydrogen | 1 | 1992 | 24 |
Why?
|
Models, Anatomic | 1 | 1992 | 27 |
Why?
|
Phosphorus | 1 | 1992 | 29 |
Why?
|
Intention to Treat Analysis | 1 | 2011 | 6 |
Why?
|
Drug Toxicity | 1 | 2011 | 16 |
Why?
|
Cell Separation | 2 | 1988 | 110 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 12 |
Why?
|
Phosphates | 1 | 1992 | 71 |
Why?
|
Ischemia | 1 | 1992 | 65 |
Why?
|
Rats, Inbred F344 | 1 | 1992 | 80 |
Why?
|
Diploidy | 1 | 1990 | 11 |
Why?
|
bcl-2-Associated X Protein | 1 | 2011 | 40 |
Why?
|
bcl-X Protein | 1 | 2011 | 32 |
Why?
|
Erythroblasts | 1 | 2011 | 13 |
Why?
|
Equipment Design | 1 | 1992 | 132 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 170 |
Why?
|
Mitogens | 1 | 1990 | 31 |
Why?
|
Surgical Flaps | 1 | 1992 | 51 |
Why?
|
Image Enhancement | 1 | 1992 | 70 |
Why?
|
Rats | 2 | 1992 | 530 |
Why?
|
Cell Count | 1 | 1990 | 163 |
Why?
|
Cell Communication | 1 | 1990 | 72 |
Why?
|
Transferrin | 1 | 1989 | 22 |
Why?
|
Markov Chains | 1 | 2009 | 25 |
Why?
|
Tumor Burden | 1 | 2009 | 12 |
Why?
|
Etoposide | 1 | 2009 | 37 |
Why?
|
Gastrointestinal Tract | 1 | 2009 | 26 |
Why?
|
Survival Analysis | 1 | 2011 | 205 |
Why?
|
Fluorescent Dyes | 1 | 1990 | 115 |
Why?
|
Cell Division | 3 | 1988 | 273 |
Why?
|
Double-Blind Method | 1 | 2011 | 274 |
Why?
|
Vomiting | 1 | 2009 | 45 |
Why?
|
Dexamethasone | 1 | 1989 | 109 |
Why?
|
Biopsy | 1 | 1989 | 207 |
Why?
|
Benzimidazoles | 1 | 1988 | 16 |
Why?
|
Dyspepsia | 1 | 2007 | 2 |
Why?
|
Sweat | 1 | 2007 | 5 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 243 |
Why?
|
Pulmonary Fibrosis | 1 | 1988 | 48 |
Why?
|
Diarrhea | 1 | 2007 | 41 |
Why?
|
Insulin | 1 | 1990 | 129 |
Why?
|
Logistic Models | 1 | 2009 | 251 |
Why?
|
Disease Progression | 1 | 2009 | 244 |
Why?
|
Incidence | 1 | 2008 | 336 |
Why?
|
Algorithms | 1 | 2009 | 226 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2005 | 4 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2005 | 5 |
Why?
|
Mice, Inbred DBA | 1 | 2005 | 38 |
Why?
|
Kidney | 1 | 2009 | 223 |
Why?
|
Young Adult | 1 | 2009 | 380 |
Why?
|
Risk Assessment | 1 | 2009 | 324 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 277 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2005 | 43 |
Why?
|
DNA | 1 | 1990 | 262 |
Why?
|
Propidium | 1 | 2004 | 3 |
Why?
|
Cytogenetic Analysis | 1 | 2004 | 11 |
Why?
|
Splenic Diseases | 1 | 2003 | 13 |
Why?
|
Splenectomy | 1 | 2003 | 29 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2004 | 29 |
Why?
|
Pregnancy | 1 | 1989 | 455 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2003 | 27 |
Why?
|
Fluorouracil | 1 | 2004 | 49 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2003 | 35 |
Why?
|
Pyrazoles | 1 | 2003 | 42 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2003 | 45 |
Why?
|
Interferon-gamma | 1 | 2005 | 133 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 99 |
Why?
|
Cyclooxygenase 2 | 1 | 2003 | 77 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 66 |
Why?
|
Rats, Sprague-Dawley | 1 | 2004 | 257 |
Why?
|
Membrane Proteins | 1 | 2003 | 233 |
Why?
|
Transplantation, Homologous | 1 | 1999 | 94 |
Why?
|
RNA, Messenger | 1 | 2005 | 394 |
Why?
|
Data Display | 1 | 1990 | 15 |
Why?
|
Reference Standards | 1 | 1990 | 35 |
Why?
|
Fluorescence | 1 | 1990 | 46 |
Why?
|
Microcomputers | 1 | 1988 | 10 |
Why?
|
Fluorescent Antibody Technique | 1 | 1988 | 164 |
Why?
|
Lymphocytes | 1 | 1988 | 142 |
Why?
|
Lymphocyte Activation | 1 | 1988 | 137 |
Why?
|
